Stevanato Group S.p.A.'s latest marketcap:
As of 07/05/2025, Stevanato Group S.p.A.'s market capitalization has reached $6.71 B. According to our data, Stevanato Group S.p.A. is the 2675th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 6.71 B |
| Revenue (ttm) | 1.22 B |
| Net Income (ttm) | 135.63 M |
| Shares Out | 272.9 M |
| EPS (ttm) | 0.5 |
| Forward PE | 38.99 |
| Ex-Dividend Date | 06/05/2025 |
| Earnings Date | 08/05/2025 |
Stevanato Group S.p.A.'s yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 07/05/2025 | $6.71 B | 12.35% | 2675 |
| 12/31/2024 | $5.95 B | -18.16% | 2610 |
| 12/29/2023 | $7.27 B | 52.74% | 2121 |
| 12/30/2022 | $4.76 B | -19.96% | 2808 |
| 12/31/2021 | $5.94 B | 2791 |
Company Profile
About Stevanato Group S.p.A.
Stevanato Group S.p.A. is a global leader in providing innovative solutions for the biopharma and healthcare industries. Headquartered in Piombino Dese, Italy, the company operates across Europe, the Middle East, Africa, North America, South America, and the Asia Pacific.
Business Segments
- Biopharmaceutical and Diagnostic Solutions: Offers drug containment, in-vitro diagnostics, and drug delivery systems.
- Engineering: Provides analytical services, medical devices, and manufacturing equipment.
Products and Services
- Drug Containment: Pre-fillable syringes, cartridges, vials, and ampoules.
- Drug Delivery Systems: Pen injectors, auto-injectors, and wearable injectors.
- Diagnostic Solutions: Laboratory consumables and regulatory support.
- Machinery: Pharmaceutical visual inspection, assembling, packaging, and glass forming machines.
- After-Sales Support: Spare parts and maintenance services.
- Contract Manufacturing: Development and production of drug delivery devices.
Customer Base
The company serves a diverse range of clients, including:
- Pharmaceutical and biotechnology firms.
- Diagnostics and life sciences companies.
- Contract manufacturers in drug product, glass packaging, and fill & finish operations.
Founded in 1949, Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L., continuing its legacy of innovation and excellence in the healthcare sector.
Frequently Asked Questions
-
What is Stevanato Group S.p.A.'s (STVN) current market cap?As of 07/05/2025, Stevanato Group S.p.A. (including the parent company, if applicable) has an estimated market capitalization of $6.71 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Stevanato Group S.p.A. (STVN) rank globally by market cap?Stevanato Group S.p.A. global market capitalization ranking is approximately 2675 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.